1. Stocks
    2. /
  2. Telix Pharmaceuticals (ASX: TLX)
    3. /

Telix Pharmaceuticals (ASX: TLX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Telix Pharmaceuticals Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Telix Pharmaceuticals (ASX: TLX)
    Latest News

    Scientist looking at a laptop thinking about the share price performance.
    Healthcare Shares

    Why are ASX healthcare shares dragging on the ASX 200 today?

    | Sebastian Bowen

    Healthcare stocks are dragging on the markets today, led by one in particular...

    Read more »

    Five guys in suits wearing brightly coloured masks, they are corporate superheroes.
    Best Shares

    Which ASX 200 market sector has been the best performer over 10 years?

    | Bronwyn Allen

    This might surprise you...

    Read more »

    A disappointed lab researcher sits in her lab looking at her clipboard with her hand to her face as she worries about the Imugene share price today
    Healthcare Shares

    Up 86% in 2024, why is the Telix Pharmaceuticals share price tumbling today?

    | Bernd Struben

    ASX 200 investors are bidding down the Telix Pharmaceuticals share price today. But why?

    Read more »

    A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
    Share Fallers

    Why Brainchip, Gold Road, Mesoblast, and Telix shares are tumbling today

    | James Mickleboro

    These shares are having a tough time on hump day. But why?

    Read more »

    Two kids play joyfully in the crashing waves.
    Healthcare Shares

    2 ASX healthcare shares making splashes in the US

    | Zach Bristow

    These two names could see significant growth in the United States.

    Read more »

    A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
    Share Market News

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a dire day on the ASX boards this Thursday...

    Read more »

    Motley Fool TV

    Motley Fool TV – July 2024

    | Motley Fool Staff

    How inflation, elections, and ASX earnings shape markets.

    Read more »

    A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
    Share Fallers

    Why Argosy Minerals, Flight Centre, Mesoblast, and Telix shares are sinking today

    | James Mickleboro

    These shares are having a tough time on hump day. But why?

    Read more »

    Shot of a scientist using a computer while conducting research in a laboratory.
    Healthcare Shares

    Telix Pharmaceuticals share price sinks 5% on giant debt deal

    | Mitchell Lawler

    This high-growth drug developer is turning to debt for its next wave of expansion.

    Read more »

    Man on a laptop thinking.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a Garfield-eque start to the trading week this Monday.

    Read more »

    A young woman with her mouth open and her hands out showing surprise and delight as uranium share prices skyrocket
    Healthcare Shares

    Buy this high-flying ASX healthcare stock for market-beating returns

    | James Mickleboro

    Bell Potter thinks this top stock could keep rising from where it trades today.

    Read more »

    A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
    Share Market News

    5 things to watch on the ASX 200 on Friday

    | James Mickleboro

    Will the market finish the week on a high? Let's find out.

    Read more »

    Frequently Asked Questions

    No, Telix does not pay dividends at this time. 

    Telix Pharmaceuticals Ltd listed on the ASX on 15 November 2017.

    TLX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Telix Pharmaceuticals

    Telix Pharmaceuticals Ltd (ASX: TLX) is a commercial-stage biopharmaceutical company focused on the ongoing development of diagnostic and therapeutic ('theranostic') products using targeted radiation. This process treats cancerous or diseased cells, an alternative approach to many cancer therapies which also attack healthy tissue at the same time.

    Telix has received global regulatory approvals from the Australian Therapeutic Goods Administration (TGA), the US Food and Drug Administration (FDA), and Health Canada for its prostate cancer imaging agent Illuccix. It is working to get Illuccix approved for sale in the UK and Europe. 

    The company also has more than 20 clinical trials underway worldwide. Telix's research and development is focused on prostate, renal (kidney), glioblastoma (brain), and hematologic (bone marrow conditioning) cancers, as well as rare diseases. The company is headquartered in Australia with offices in Belgium, Japan, Switzerland, and the United States. 

    Profile

    since

    Note